Comparison of weight loss effect of diabetes treatment for obese type 2 diabetic patients.

Comparison of weight loss effect of diabetes treatment for obese type 2 diabetic patients. - Comparison of weight loss effect of diabetes treatment for obese type 2 diabetic patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027835

Enrollment

Registered

2017-06-26

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

The group treated with GLP-1 receptor agonist(Duration:6 months) The group treated with SGLT-2 inhibitor(Duration:6 months) The group treated with GLP-1 receptor agonist and SGLT-2 inhibitor(Duration:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: BMI>=22.0

Exclusion criteria

Exclusion criteria: Renal dysfunction(eGFR>=30mL/min/1.73m2)

Design outcomes

Primary

Measure	Time frame
HbA1c(0M,6M)	—

Secondary

Measure	Time frame
BMI(0M,6M)	—

Countries

Japan

Contacts

Public ContactTakahisa Hasegawa

KYORITSU HOSPITAL internal medicine

h.taka517@gmail.com072-758-1131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026